---
layout: minimal-medicine
nav_exclude: true
title: Nadroparin
---

# Nadroparin

**Generic Name:** Nadroparin Calcium

**Usage:** Nadroparin calcium is a low-molecular-weight heparin (LMWH) used to prevent and treat blood clots (thromboembolism).  Specific uses include:

* **Prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) after surgery:** Particularly in patients undergoing major surgery, orthopedic procedures (like hip or knee replacement), or abdominal surgery.
* **Treatment of DVT and PE:**  It's used in conjunction with other treatments.
* **Treatment of unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI):** In combination with other therapies.  This use is less common than the above.

**Side Effects:** Like all medications, nadroparin can cause side effects.  These can range from mild to severe.  Common side effects include:

* **Bleeding:** This is the most common and serious side effect.  It can range from minor bruising to severe hemorrhage.
* **Injection site reactions:** Pain, bruising, swelling, redness, or discoloration at the injection site.
* **Thrombocytopenia:** A decrease in platelet count, which can increase the risk of bleeding.  This is rare but serious.
* **Heparin-induced thrombocytopenia (HIT):** A rare but serious condition where the body forms antibodies against heparin, leading to a paradoxical increase in clotting risk.
* **Nausea and vomiting**
* **Headache**
* **Allergic reactions:**  Rash, itching, hives, difficulty breathing.


**How it Works:** Nadroparin is a low-molecular-weight heparin (LMWH).  Unlike unfractionated heparin (UFH), LMWHs have a smaller molecular size. This allows them to bind more selectively to antithrombin III (ATIII), a natural anticoagulant.  This enhanced binding increases the inhibition of factor Xa, a key factor in the coagulation cascade.  While it also inhibits thrombin (factor IIa), to a lesser extent than UFH, its primary mechanism is through factor Xa inhibition.  This leads to a reduced risk of blood clot formation.

**FAQs:**

* **How is nadroparin administered?** Nadroparin is administered via subcutaneous injection (under the skin).  Never administer it intravenously.
* **How often is nadroparin administered?** The dosage and frequency of nadroparin depend on the specific condition being treated and the patient's individual needs. Your doctor will determine the appropriate dosage and schedule.
* **What should I do if I miss a dose?**  Contact your doctor or pharmacist immediately if you miss a dose.  Do not double up on doses.
* **What are the interactions with other medications?**  Nadroparin can interact with other medications, including anticoagulants (like warfarin), antiplatelet drugs (like aspirin), and NSAIDs.  Inform your doctor of all medications you are taking.
* **What should I monitor for while taking nadroparin?**  Monitor for signs of bleeding, such as bruising, unusual bleeding, or dark stools.  Report any unusual symptoms to your doctor immediately.
* **Is nadroparin safe during pregnancy or breastfeeding?**  The safety of nadroparin during pregnancy and breastfeeding should be discussed with your doctor.  The benefits and risks need to be carefully weighed.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice. Always consult with your doctor or other qualified healthcare professional before starting, stopping, or changing any medication.  They can assess your individual needs and determine the appropriate dosage and monitoring plan for you.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.